NASDAQ:CENT - Central Garden & Pet Stock Price, News & Analysis

Central Garden & Pet trades on the NASDAQ under the ticker symbol "CENT."

Central Garden & Pet Co (NASDAQ:CENT) released its quarterly earnings data on Thursday, August, 1st. The company reported $0.80 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by $0.06. The business earned $706.60 million during the quarter, compared to the consensus estimate of $685.99 million. Central Garden & Pet had a net margin of 4.30% and a return on equity of 9.66%. The firm's quarterly revenue was up 7.4% on a year-over-year basis. During the same period last year, the business posted $0.79 earnings per share. View Central Garden & Pet's Earnings History.

Central Garden & Pet is scheduled to release their next quarterly earnings announcement on Tuesday, November 26th 2019. View Earnings Estimates for Central Garden & Pet.

Central Garden & Pet updated its FY19 earnings guidance on Thursday, August, 1st. The company provided earnings per share guidance of $1.72 or higher for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.81.

4 Wall Street analysts have issued 12-month target prices for Central Garden & Pet's shares. Their forecasts range from $30.00 to $37.00. On average, they expect Central Garden & Pet's share price to reach $34.3333 in the next twelve months. This suggests a possible upside of 26.0% from the stock's current price. View Analyst Price Targets for Central Garden & Pet.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Central Garden & Pet in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Central Garden & Pet.

News headlines about CENT stock have trended negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Central Garden & Pet earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Central Garden & Pet.

Central Garden & Pet saw a drop in short interest in the month of August. As of August 31st, there was short interest totalling 1,044,800 shares, a drop of 7.2% from the July 31st total of 1,125,600 shares. Based on an average daily trading volume, of 125,300 shares, the short-interest ratio is currently 8.3 days. Currently, 10.2% of the shares of the company are sold short. View Central Garden & Pet's Current Options Chain.

Some companies that are related to Central Garden & Pet include PVH (PVH), Dolby Laboratories (DLB), Madison Square Garden (MSG), ITV PLC/ADR (ITVPY), TUI AG/ADR (TUIFY), Sharp (SHCAY), Grupo Televisa SAB (TV), SJM (SJMHF), Planet Fitness (PLNT), MERLIN ENTERTAI/S (MERLY), World Wrestling Entertainment (WWE), Zynga (ZNGA), Leggett & Platt (LEG), Skechers USA (SKX) and Grand Canyon Education (LOPE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Central Garden & Pet investors own include Vereit (VER), General Electric (GE), Skechers USA (SKX), Cracker Barrel Old Country Store (CBRL), Jack in the Box (JACK), Lululemon Athletica (LULU), Virtu Financial (VIRT), Kroger (KR), Scotts Miracle-Gro (SMG) and Zoetis (ZTS).

Central Garden & Pet's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (2.89%), Wells Fargo & Company MN (2.32%), Vanguard Group Inc. (2.28%), Bank of America Corp DE (1.87%), Atlanta Capital Management Co. L L C (1.38%) and Renaissance Technologies LLC (0.85%). Company insiders that own Central Garden & Pet stock include Brooks Pennington III, George A Yuhas, George C Roeth, Howard Machek, John Ranelli, Mary Beth Springer, Michael A Reed, Michael Edwards, Nicholas Lahanas and Thomas J Colligan. View Institutional Ownership Trends for Central Garden & Pet.

CENT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Marshall Wace LLP, Citadel Advisors LLC, Grantham Mayo Van Otterloo & Co. LLC, First Quadrant L P CA, Eqis Capital Management Inc., GW&K Investment Management LLC and Acadian Asset Management LLC. Company insiders that have sold Central Garden & Pet company stock in the last year include Brooks Pennington III, George A Yuhas, George C Roeth and Mary Beth Springer. View Insider Buying and Selling for Central Garden & Pet.

CENT stock was bought by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Wells Fargo & Company MN, Earnest Partners LLC, Atlanta Capital Management Co. L L C, Marshall Wace North America L.P., BlackRock Inc., Northern Trust Corp and Virginia Retirement Systems ET AL. Company insiders that have bought Central Garden & Pet stock in the last two years include Michael Edwards and Thomas J Colligan. View Insider Buying and Selling for Central Garden & Pet.

Shares of CENT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CENT stock can currently be purchased for approximately $27.25.

Central Garden & Pet has a market capitalization of $1.58 billion and generates $2.22 billion in revenue each year. The company earns $123.59 million in net income (profit) each year or $1.91 on an earnings per share basis. Central Garden & Pet employs 5,400 workers across the globe.View Additional Information About Central Garden & Pet.

The official website for Central Garden & Pet is http://www.central.com/.

Central Garden & Pet's mailing address is 1340 TREAT BOULEVARD SUITE 600, WALNUT CREEK CA, 94597. The company can be reached via phone at 925-948-4000 or via email at [email protected]